T. Rowe Price Investment Management
KRTX

T. Rowe Price Investment Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,709,629
Closed -$858M 668
2023
Q4
$858M Sell
2,709,629
-32,828
-1% -$10.4M 0.56% 48
2023
Q3
$464M Buy
2,742,457
+263,422
+11% +$44.5M 0.33% 97
2023
Q2
$538M Sell
2,479,035
-1,730
-0.1% -$375K 0.37% 79
2023
Q1
$451M Buy
2,480,765
+1,278,134
+106% +$232M 0.32% 92
2022
Q4
$236M Buy
1,202,631
+229,374
+24% +$45.1M 0.18% 138
2022
Q3
$219M Buy
+973,257
New +$219M 0.17% 136